LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Fleischmann, R. [1 ]
van Vollenhoven, R. [2 ]
Vencovsky, J. [3 ]
Alten, R. [4 ]
Davies, O. [5 ]
Stach, C. [6 ]
de Longueville, M. [5 ]
VanLunen, B. [7 ]
Choy, E. [8 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA
[2] Karolinska Inst, Stockholm, Sweden
[3] Inst Rheumatol, Prague, Czech Republic
[4] Charite, Schlosspk Klin, D-13353 Berlin, Germany
[5] UCB Pharma, Brussels, Belgium
[6] UCB Pharma, Monheim, Germany
[7] UCB Pharma, Raleigh, NC USA
[8] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [41] Combination Therapy with Certolizumab Pegol Plus Methotrexate Maintains Long-term Efficacy in the Treatment of Rheumatoid Arthritis: A 2-year Analysis
    Haraoui, Paul
    Keystone, Edward
    Schiff, Michael
    Mease, Philip
    van Vollenhoven, Ronald F.
    Desai, Chintu
    Smolen, Josef
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2572 - 2572
  • [42] Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
    Kavanaugh, Arthur
    Westhovens, Rene R.
    Winthrop, Kevin L.
    Lee, Susan J.
    Tan, YingMeei
    An, Di
    Ye, Lei
    Sundy, John S.
    Besuyen, Robin
    Meuleners, Luc
    Stanislavchuk, Mykola
    Spindler, Alberto J.
    Greenwald, Maria
    Alten, Rieke
    Genovese, Mark C.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (08) : 1230 - 1238
  • [43] Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study
    Taylor, P.
    Genovese, M.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    Lundmark, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 59 - 59
  • [44] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Taylor, Peter
    Genovese, Mark
    Keystone, Ed
    Schlichting, Douglas
    Beattie, Scott
    Macias, William
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A31 - A31
  • [45] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis.
    Keystone, Edward C.
    Taylor, Peter C.
    Genovese, Mark C.
    Schlichting, Douglas E.
    De La Torre, Inmaculada
    Beattie, Scott D.
    Rooney, Terence
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1232 - S1232
  • [46] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Taylor, P.
    Genovese, M. C.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 65 - 66
  • [47] CLINICAL OUTCOMES OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB MONOTHERAPY IN THE OPEN-LABEL LONG-TERM EXTENSION
    Fleischmann, R.
    Wollenhaupt, J.
    Wang, L.
    Maniccia, A.
    Kwok, K.
    Takiya, L.
    van Vollenhoven, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 259 - 260
  • [48] Long-Term Efficacy and Safety of Romiplostim for the Treatment of Patients with Chronic Immune Thrombocytopenia (ITP): 5-Year Update From An Open-Label Extension Study
    Bussel, James B.
    Kuter, David J.
    Newland, Adrian
    de Wolf, Joost T. M.
    Wasser, Jeffrey
    Chang, Paul
    Nie, Kun
    Berger, Dietmar
    BLOOD, 2009, 114 (22) : 285 - 285
  • [49] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06) : 950 - 959
  • [50] Long-Term Safety and Efficacy of Bimekizumab in Patients with Active Ankylosing Spondylitis: 5-Year Results from a Phase 2b Study and Its Open-Label Extension
    Deodhar, Atul
    Navarro-Compan, Victoria
    Poddubnyy, Denis
    Gensler, Lianne
    Ramiro, Sofia
    Tomita, Tetsuya
    Marzo-Ortega, Helena
    Fleurinck, Carmen
    Vaux, Thomas
    Massow, Ute
    van der Heijde, Desiree
    Baraliakos, Xenofon
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1014 - 1017
12345